This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pressman, D. Search for Related Content PubMed PubMed Citation Articles by Pressman, D.

The Development and Use of Radiolabeled Antitumor Antibodies¹

Department of Immunology Research, Roswell Park Memorial Institute, Buffalo, New York 14263

The use of radioactive tumor-localizing antibodies is developed historically, starting with the demonstration that antibodies can be radioiodinated without destroying antibody activity. Then, antibodies against normal organs were shown to contain antibodies which localize in the normal organ. Subsequently, antibodies capable of localizing in tumors were demonstrated, and these localized well enough to permit their use diagnostically by scanning for radioactivity and their use therapeutically by localizing sufficient radioiodine. Various relevant problems are discussed.

¹ Presented at the UICC Workshop on Radioimmunodetection of Cancer, July 19 to 21, 1979, Lexington, Ky.

² Deceased.